Wine Compounds as a Source for HTS Screening Collections. A Feasibility Study

High throughput screening (HTS) is extensively used to identify hit and lead compounds in drug discovery programmes. Designing quality screening libraries is a challenge in terms of water solubility, stability and potential oral bioavailability of the compounds. Wines are widely consumed and wine compounds are inherently water soluble, stable and relatively non‐toxic. Furthermore, many wine compounds have been proved health‐beneficial. To evaluate the feasibility to use wine compounds 3317 were collected from the literature. Their physiochemical properties were evaluated with main stream molecular descriptors. According to the results ∼25 % of the compounds are lead‐like; nearly 80 % lie within drug‐like chemical space and finally 90 % conform to known drug space (KDS). The rotatable bonds descriptor was the most effective defining lead‐like space. The results suggest that many of the wine compounds are interesting and suitable candidates for screening libraries after suitable filtering.

[1]  Nicolas Foloppe,et al.  Drug-like Annotation and Duplicate Analysis of a 23-Supplier Chemical Database Totalling 2.7 Million Compounds , 2004, J. Chem. Inf. Model..

[2]  D. Pereira,et al.  Origin and evolution of high throughput screening , 2007, British journal of pharmacology.

[3]  S. Yalkowsky,et al.  Estimation of the aqueous solubility I: application to organic nonelectrolytes. , 2001, Journal of pharmaceutical sciences.

[4]  B. Jayaprakasam,et al.  Impact of alkyl esters of caffeic and ferulic acids on tumor cell proliferation, cyclooxygenase enzyme, and lipid peroxidation. , 2006, Journal of agricultural and food chemistry.

[5]  Stephen R. Johnson,et al.  Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.

[6]  P. Coumel,et al.  [Long-term clinical results of the implantable automatic defibrillator]. , 1987, Archives des maladies du coeur et des vaisseaux.

[7]  De-Xing Hou,et al.  Potential mechanisms of cancer chemoprevention by anthocyanins. , 2003, Current molecular medicine.

[8]  J. Hollis,et al.  Analysis of betaine and choline contents of aleurone, bran, and flour fractions of wheat (Triticum aestivum L.) Using (1)H nuclear magnetic resonance (NMR) spectroscopy. , 2009, Journal of agricultural and food chemistry.

[9]  Matthew A Cooper,et al.  Drug-likeness and increased hydrophobicity of commercially available compound libraries for drug screening. , 2012, Current topics in medicinal chemistry.

[10]  J. Hughes,et al.  Physiochemical drug properties associated with in vivo toxicological outcomes. , 2008, Bioorganic & medicinal chemistry letters.

[11]  Jóhannes Reynisson,et al.  Characteristics of known drug space. Natural products, their derivatives and synthetic drugs. , 2010, European journal of medicinal chemistry.

[12]  R. Barrett,et al.  XP13512 [(±)-1-([(α-Isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane Acetic Acid], A Novel Gabapentin Prodrug: I. Design, Synthesis, Enzymatic Conversion to Gabapentin, and Transport by Intestinal Solute Transporters , 2004, Journal of Pharmacology and Experimental Therapeutics.

[13]  Tudor I. Oprea,et al.  Is There a Difference between Leads and Drugs? A Historical Perspective , 2001, J. Chem. Inf. Comput. Sci..

[14]  P. Davidson,et al.  Antimicrobials in foods. , 1993 .

[15]  Eric F. Johnson,et al.  Synthesis and SAR of novel tricyclic quinoxalinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1). , 2009, Bioorganic & medicinal chemistry letters.

[16]  P. Hajduk,et al.  Cheminformatic tools for medicinal chemists. , 2010, Journal of medicinal chemistry.

[17]  K. Roemer,et al.  The basis for the chemopreventive action of resveratrol. , 2002, Drugs of today.

[18]  N. Seeram,et al.  Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. , 2004, Anticancer research.

[19]  N. Seeram,et al.  Cyclooxygenase inhibitory and antioxidant compounds from crabapple fruits. , 2003, Journal of agricultural and food chemistry.

[20]  P. Kilmartin,et al.  Influence of grape-harvesting steps on varietal thiol aromas in Sauvignon blanc wines. , 2011, Journal of agricultural and food chemistry.

[21]  D. Newman,et al.  Natural products as sources of new drugs over the last 25 years. , 2007, Journal of natural products.

[22]  P. Workman,et al.  The identification of novel PLC-gamma inhibitors using virtual high throughput screening. , 2009, Bioorganic & medicinal chemistry.

[23]  Norman L. Allinger,et al.  Conformational analysis. 130. MM2. A hydrocarbon force field utilizing V1 and V2 torsional terms , 1977 .

[24]  P. Leeson,et al.  A comparison of physiochemical property profiles of development and marketed oral drugs. , 2003, Journal of medicinal chemistry.

[25]  Jóhannes Reynisson,et al.  Investigation of the incidence of "undesirable" molecular moieties for high-throughput screening compound libraries in marketed drug compounds. , 2009, European journal of medicinal chemistry.

[26]  C. Szabó,et al.  The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors , 2002, Pharmacological Reviews.

[27]  F. Scheer,et al.  Daily Nighttime Melatonin Reduces Blood Pressure in Male Patients With Essential Hypertension , 2004, Hypertension.

[28]  M. Nair,et al.  Relative inhibition of lipid peroxidation, cyclooxygenase enzymes, and human tumor cell proliferation by natural food colors. , 2005, Journal of agricultural and food chemistry.

[29]  Tudor I. Oprea,et al.  Current trends in lead discovery: Are we looking for the appropriate properties? , 2004, Molecular Diversity.

[30]  D. Trist,et al.  The continuing evolution of the drug discovery process in the pharmaceutical industry. , 2001, Farmaco.

[31]  R. Torella,et al.  Red wine consumption improves insulin resistance but not endothelial function in type 2 diabetic patients. , 2005, Metabolism: clinical and experimental.

[32]  F. Speizer,et al.  Beverage Use and Risk for Kidney Stones in Women , 1998, Annals of Internal Medicine.

[33]  P. Chatonnet,et al.  Elebage des vins rouges en fûts de chêne : évolution de certains composés volatils et de leur impact arômatique , 1990 .

[34]  T. O'Brien,et al.  Fragment-based drug discovery. , 2004, Journal of medicinal chemistry.

[35]  Li Xing,et al.  Influence of molecular flexibility and polar surface area metrics on oral bioavailability in the rat. , 2004, Journal of medicinal chemistry.

[36]  Wendy A. Warr,et al.  Fragment-based drug discovery , 2009, J. Comput. Aided Mol. Des..

[37]  G. Rishton Reactive compounds and in vitro false positives in HTS , 1997 .

[38]  M. Fontecave,et al.  Resveratrol, a remarkable inhibitor of ribonucleotide reductase , 1998, FEBS letters.

[39]  Christopher P Austin,et al.  Quantitative analyses of aggregation, autofluorescence, and reactivity artifacts in a screen for inhibitors of a thiol protease. , 2010, Journal of medicinal chemistry.

[40]  D. Goldberg,et al.  Wine and Health: A Paradigm for Alcohol and Antioxidants , 2010 .

[41]  P. Kilmartin,et al.  Influence of juice pressing conditions on polyphenols, antioxidants, and varietal aroma of Sauvignon blanc microferments. , 2010, Journal of agricultural and food chemistry.

[42]  G. Rishton Nonleadlikeness and leadlikeness in biochemical screening. , 2003, Drug discovery today.

[43]  J. Baell,et al.  New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. , 2010, Journal of medicinal chemistry.

[44]  Jóhannes Reynisson,et al.  Benchmarking the reliability of QikProp. Correlation between experimental and predicted values , 2008 .

[45]  I. Reynisdottir,et al.  The effect of PLC-γ2 inhibitors on the growth of human tumour cells. , 2012, European journal of medicinal chemistry.